CMP — Compumedics Income Statement
0.000.00%
Last trade - 00:00
- AU$47.83m
- AU$53.39m
- AU$42.41m
- 90
- 77
- 88
- 96
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 41.5 | 35.1 | 35.7 | 37.8 | 42.4 |
Cost of Revenue | |||||
Gross Profit | 24.8 | 18 | 19.2 | 19.3 | 21.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 36.2 | 42.2 | 33.8 | 35.8 | 48.5 |
Operating Profit | 5.35 | -7.08 | 1.91 | 1.93 | -6.11 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 5.09 | -7.5 | 0.776 | 1.7 | -6.72 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.02 | -5.84 | 0.998 | 1.36 | -6.12 |
Net Income Before Extraordinary Items | |||||
Net Income | 4.02 | -5.84 | 0.998 | 1.36 | -6.12 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.02 | -5.84 | 0.998 | 1.36 | -6.12 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.023 | -0.008 | 0.002 | 0.003 | -0.023 |